Related Experiment Video
Updated: Aug 12, 2025

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
Unlocking G-Quadruplexes as Targets and Tools against COVID-19
Geng Qin1,2, Chuanqi Zhao1,2, Jie Yang1,2
1Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Science Changchun, Jilin 130022 China.
Abstract:
The applicability of G-quadruplexes (G4s) as antiviral targets, therapeutic agents and diagnostic tools for coronavirus disease 2019 (COVID-19) is currently being evaluated, which has drawn the extensive attention of the scientific community. During the COVID-19 pandemic, research in this field is rapidly accumulating. In this review, we summarize the latest achievements and breakthroughs in the use of G4s as antiviral targets, therapeutic agents and diagnostic tools for COVID-19, particularly using G4 ligands. Finally, strength and weakness regarding G4s in anti-SARS-CoV-2 field are highlighted for prospective future projects.
Insights
G-quadruplexes (G4s) show promise as COVID-19 treatments and diagnostics. Research is rapidly advancing on G4 ligands targeting SARS-CoV-2, highlighting their potential and limitations for future antiviral strategies.
Area of Science:
- Biochemistry and Molecular Biology
- Virology
- Medicinal Chemistry
Background:
- The COVID-19 pandemic spurred research into novel therapeutic and diagnostic strategies.
- G-quadruplexes (G4s) are emerging as potential targets due to their unique structural properties.
- The scientific community is actively investigating G4s for their role in combating SARS-CoV-2.
Purpose of the Study:
- To review recent advancements in utilizing G-quadruplexes (G4s) against COVID-19.
- To explore the application of G4s as antiviral targets, therapeutic agents, and diagnostic tools.
- To summarize the use of G4 ligands in anti-SARS-CoV-2 research.
Main Methods:
- Literature review of current research on G-quadruplexes and COVID-19.
- Analysis of studies focusing on G4 ligands targeting SARS-CoV-2.
- Synthesis of findings on G4s as therapeutic and diagnostic modalities.
Main Results:
- G-quadruplexes (G4s) are being actively evaluated for their potential in COVID-19 management.
- G4 ligands demonstrate promise as antiviral agents and diagnostic tools against SARS-CoV-2.
- Accumulating research highlights the expanding role of G4s in the anti-SARS-CoV-2 field.
Conclusions:
- G-quadruplexes (G4s) and their ligands represent a significant area of investigation for COVID-19.
- Further research is needed to fully elucidate the strengths and weaknesses of G4s in combating SARS-CoV-2.
- G4-based strategies offer a promising avenue for future antiviral therapies and diagnostics.
Related Concept Videos
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs

